Prevalence of serologic markers of hepatitis A, B, C, and D viruses in pregnant women

OBJECTIVETo determine the seroprevalence of hepatitis A, B, C and D virus infection among pregnant women attending a perinatal care hospital.MATERIAL AND METHODSA prospective study was carried out to determine the seroprevalence of hepatitis A virus IgG antibodies (anti-HAV), hepatitis B virus marke...

Full description

Saved in:
Bibliographic Details
Published inSalud pública de México Vol. 38; no. 5; pp. 317 - 322
Main Authors Ortiz-Ibarra, F J, Figueroa-Damián, R, Lara-Sánchez, J, Arredondo-García, J L, Ahued-Ahued, J R
Format Journal Article
LanguageSpanish
Published 01.09.1996
Online AccessGet full text

Cover

More Information
Summary:OBJECTIVETo determine the seroprevalence of hepatitis A, B, C and D virus infection among pregnant women attending a perinatal care hospital.MATERIAL AND METHODSA prospective study was carried out to determine the seroprevalence of hepatitis A virus IgG antibodies (anti-HAV), hepatitis B virus markers (anti-HBcAg and HBsAg) and hepatitis C virus antibodies (anti-HCV) in pregnant women. In HBsAg positive cases. HBeAg and hepatitis D virus antibodies (anti-HDV) were investigated. All analyses were performed with the ELISA technique.RESULTSOf the 1500 pregnant women studied. 93.3% were positive for anti-HAV IgG. The HBsAg seroprevalence was 0.26% and anti-HCV seroprevalence was 0.53%. There were no patients with HBeAg or anti-HDV.CONCLUSIONSA higher seroprevalence of HBsAg was found in this study than in other studies of pregnant Mexican women. We propose that HBsAg screening become a routine prenatal test.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-1
ISSN:0036-3634